Company intelligence / Profile preview

ProRhythm

Ronkonkoma, New York, United Statesbiospace.com ↗

Ownership: Private
Development stage: Phase 3

Overview

ProRhythm developed a steerable HIFU Ablation Balloon Catheter for minimally invasive treatment of atrial fibrillation. The company’s device entered U.S. pivotal clinical trials after successful feasibility studies, with European trials showing that many patients experienced complete elimination of AF symptoms after a single procedure. However, in December 2007 the company filed for Chapter 11 bankruptcy protection and sought restructuring due to financing difficulties. There is no public evidence that it emerged from bankruptcy or continued operations beyond this period.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on ProRhythm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProRhythm.

Explore the full profile